Last reviewed · How we verify
NCT07017881
The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia
NA trial testing Psychosocial Skills Training in Schizophenia Disorder in 48 participants. Completed in 18 October 2024.
9 August 2024
Quick facts
| Lead sponsor | Neslihan Lok |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 48 |
| Start date | 5 August 2024 |
| Primary completion | 9 August 2024 |
| Estimated completion | 18 October 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Psychosocial Skills Training
Conditions studied
- Schizophenia Disorder — all drugs for Schizophenia Disorder →
- Psychiatric Nursing — all drugs for Psychiatric Nursing →
- Psychosocial Skills Training — all drugs for Psychosocial Skills Training →
Sponsor
Neslihan Lok
Who can join
Adults 18 to 65, any sex, with Schizophenia Disorder or Psychiatric Nursing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. The research was conducted with 48 schizophrenia patients (Experimental: 24, Control: 24) registered in the Mental Health and Diseases Outpatient Clinic of a hospital. Personal Information Form, Subjective Recovery Assessment Scale, Rosenberg Self-Esteem Scale, Quality of Life Scale for Schizophrenia Patients were used to collect data. Data were collected by the researcher using the self-reporting face-to-face interview method in the form of pre-test and post-test. Psychosocial Skills Training was applied to the patients in the experimental group, one session per week, two days a week for 11 weeks, while the patients in the control group did not receive any intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07017881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophenia Disorder
Currently open trials in the same condition.
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT06865937 — Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33) · NA · recruiting
- NCT06856161 — A Novel Blood Test as a Biomarker in Mental Health · recruiting
- NCT06831435 — Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study · NA · recruiting
- NCT07453420 — Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-p · active not recruiting
Other Neslihan Lok trials
Trials by the same sponsor.
- NCT07522125 — Effects of a Multicomponent Exercise Program on Frailty, Cognitive Function, and Sleep Quality in Older Adults · NA · completed
- NCT06935981 — Effectiveness of School-based Mental Health Program · NA · completed
- NCT06883734 — The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia · NA · completed
- NCT06941909 — The Effect of a Mindfulness-Based Self-Compassion Program on Care Burden, Life Satisfaction, and Coping Levels of Caregi · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07017881 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neslihan Lok
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing